How much does the Cogent Biosciences CEO make?

Andrew Robbins received $27,762,684 in total compensation for FY2025 as Chief Executive Officer of Cogent Biosciences, Inc. (COGT), per Cogent Biosciences, Inc.'s DEF 14A filed 23 Apr 2026 (accession 0001193125-26-173834).

Cogent Biosciences ceo salary

Cogent Biosciences ceo salary | rentseek.ing

Andrew Robbins, Chief Executive Officer of Cogent Biosciences, Inc. (COGT), received $27,762,684 ($27.8M) in total compensation for FY2025, up 464.5% from the prior year. Option awards of $13,447,680 were the largest component. Figures come from Cogent Biosciences, Inc.'s DEF 14A filed 23 Apr 2026 (accession 0001193125-26-173834).

Reported total from the latest DEF 14A pay table. Source filing (accession 0001193125-26-173834). These figures come from Cogent Biosciences, Inc.'s DEF 14A filed 23 Apr 2026 (accession 0001193125-26-173834).

Component	Amount
Salary	$724,554
Stock awards	$12,993,250
Option awards	$13,447,680
Cash incentive	$561,600
Other	$14,000
Total	$27,762,684

FAQ

Common questions

How much does the Cogent Biosciences CEO make?: Andrew Robbins received $27,762,684 in total compensation for FY2025 as Chief Executive Officer of Cogent Biosciences, Inc. (COGT), per Cogent Biosciences, Inc.'s DEF 14A filed 23 Apr 2026 (accession 0001193125-26-173834).
Where does this number come from?: The numbers come from Cogent Biosciences, Inc.'s DEF 14A filed 23 Apr 2026 (accession 0001193125-26-173834).